Financial reports
10-K
2023 FY
Annual report
6 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
10-K
2022 FY
Annual report
8 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
7 Mar 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
Current reports
8-K
Amendments to Articles of Incorporation or Bylaws
26 Dec 23
8-K
Other Events
16 Nov 23
8-K
Other Events
25 May 23
8-K
Entry into a Material Definitive Agreement
9 May 23
8-K
Amendments to Articles of Incorporation or Bylaws
26 Aug 22
8-K
Entry into a Material Definitive Agreement
4 Mar 21
8-K
Other Events
13 Feb 18
8-K
Entry into a Material Definitive Agreement
21 Dec 16
8-K
Completion of Acquisition or Disposition of Assets
2 Dec 16
8-K
Other Events
1 Dec 16
Registration and prospectus
D/A
Indefinite amount in Group PPVL with Fixed Account, sold $415.00 mm, 7 investors
13 Dec 23
D/A
Indefinite amount in other securities, sold $3.36 bn, 16 investors
13 Dec 23
D/A
Indefinite amount in other securities, sold $8.73 bn, 78 investors
13 Dec 23
D/A
Indefinite amount in other securities, sold $7.50 mm, 10 investors
12 Dec 23
D
Indefinite amount in other securities, sold $40.00 mm, 1 investor
12 Dec 23
D/A
Indefinite amount in other securities, sold $64.03 mm, 1 investor
12 Dec 23
D/A
Indefinite amount in other securities, sold $200.00 mm, 2 investors
12 Dec 23
D/A
Indefinite amount in other securities, sold $2.38 mm, 1 investor
12 Dec 23
S-3/A
Shelf registration (amended)
27 Mar 23
D/A
Indefinite amount in Group PPVL with Fixed Account, sold $240.00 mm, 6 investors
3 Feb 23
Proxies
No filings
Other
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
6 Mar 24
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
7 Nov 23
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
8 Aug 23
EFFECT
Notice of effectiveness
2 May 23
EFFECT
Notice of effectiveness
4 May 20
EFFECT
Notice of effectiveness
19 May 17
CORRESP
Correspondence with SEC
21 Mar 17
EFFECT
Notice of effectiveness
2 May 16
CORRESP
Correspondence with SEC
18 Apr 16
CORRESP
Correspondence with SEC
4 Apr 16